Skip to main content
. 2019 Jul 25;10:765. doi: 10.3389/fphar.2019.00765

Table 2.

Baseline characteristics of subjects who were inhaled on indacaterol (LABA) and ciclesonide (ICS). Sputum eosinophilia was demonstrated by the qualitative method. AHR, airway hyperresponsiveness.

Number of patients 21
Mean age 70.7 ± 5.4
Gender (men/women) 18/3
Duration (years) 0.99 ± 0.74
COPD stage (II/III) 13/8
Emphysema (+/−) 14/7
Sputum eosinophils (≥+/−) 21/0
AHR (+/−/?) 7/4/10
Smoking (current/ex/non) 0/21/0
Past history of asthma (+/−) 0/21